Versatile & Robust Chemical Site-Specific Conjugation Platform: AJICAP® Technology
Time: 9:00 am
day: Conference Day Two pt 1
Details:
• AJICAP® Conjugation: Examining how site-specific technologies are being employed in many of the next-generation ADCs due to the enhancement of clinically relevant biological properties observed in various preclinical studies
• AJICAP® Linker: Demonstrating a novel hydrophilic linker technology that enables the versatile synthesis of homogenous DAR = 1, 2, 4, 8, and higher
• Showcasing bispecific and trispecific antibodies produced by a fully chemical conjugation technology
